Regarding IPF, S100A4 mRNA and protein levels have been found to significantly increase in BALF compared to controls and other interstitial lung diseases (ILDs) [20,21], but also in lung tissue, as shown by immunohistochemistry studies [16,18]. Here, S100A4 is linked to interstitial lung disease.